Analyzing slides for lymph node metastasis detection is tedious and time-consuming. What if you could automate your workload without sacrificing accuracy?

Tune in March 17th at 11:00 am CET or 01:00 pm EST, for ‘Improving Diagnostic Workflows with AI: Lymph Node Metastasis Detection in Breast and Colorectal Cancer’ to learn how you can use our first multi-indication AI-assisted CE-IVD APP to efficiently order, identify, and assess metastasis in lymph nodes:

  • Improve your detection sensitivity of metastatic regions compared to current standards
  • Save time with automated slide sorting to select the slides you want to review first
  • Easily integrate this APP into your diagnostic workflow

Ready to start taking advantage of AI for metastasis detection?

Click here to register

Meet your speakers

Dr. Stine Harder, Ph.D.

Dr. Stine Harder, Ph.D.
Head of Clinical Product Management, Visiopharm

Stine Harder has a Ph.D. in Image Analysis from the Technical University of Denmark. Image analysis is her passion and she continued her research during a 2-year postdoc tenure.

In her current position, Stine oversees the complete lifecycle of Visiopharm’s clinical products.

 

Dzenita Omanovic

Dzenita Omanovic
Clinical Data and Information Lead

Dzenita Omanovic has a Master’s Degree in biomedical engineering from the Technical University of Denmark. She manages the clinical application development projects at Visiopharm.

She is responsible for the testing of the Metastasis Detection, AI APP.

Can’t make it to this webinar?
Don’t worry, sign up anyway and we will send you the recording.

Click here to register

 

Source: Visiopharm

OR

platinum partners

gold partners

Silver Partners

Media Partners